바이오인포매틱스 서비스 시장 : 분야별, 유형별, 용도별, 최종 사용자별 - 세계 예측(2025-2030년)

The Bioinformatics Services Market was valued at USD 25.49 billion in 2023, expected to reach USD 31.26 billion in 2024, and is projected to grow at a CAGR of 23.10%, to USD 109.23 billion by 2030.

Bioinformatics services encompass a broad range of analytical and computational services that aid in the collection, classification, storage, and interpretation of complex biological data. These services are vital due to the increasing volume of biological data generated by technologies such as high-throughput sequencing and the need for skilled interpretation to facilitate advancements in healthcare, pharmaceuticals, and agricultural research. The application of bioinformatics is extensive, significantly impacting genomics, proteomics, drug discovery, and personalized medicine. End-use industries such as biotechnology companies, research institutions, hospitals, and agriculture sectors leverage bioinformatics to accelerate research efficiency and innovation. The market growth is primarily driven by the surge in genomic data, the rising demand for personalized medicine, and increased government funding for research and development in life sciences. Key factors influencing growth include technological advancements, cost reduction in sequencing, and increased adoption in developing regions. Emerging opportunities lie in the integration of artificial intelligence and machine learning with bioinformatics, which can enhance data analysis accuracy and predictive modeling. Companies looking to capitalize on these opportunities should invest in AI-driven bioinformatics solutions and establish strategic collaborations with research institutes. However, the market does face challenges such as data privacy concerns, the high cost of infrastructure, and the need for skilled professionals proficient in both biology and informatics. Addressing these challenges through improved cybersecurity measures, cost-effective solutions, and comprehensive training programs can spur market growth. Innovation areas include cloud-based bioinformatics platforms and developing user-friendly interfaces to facilitate broader adoption among non-specialist users. The nature of the bioinformatics market is dynamic, with a competitive landscape marked by rapid technological changes and evolving customer demands, pointing to both significant opportunity and challenge for stakeholders aiming to drive future growth and development.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bioinformatics Services Market

The Bioinformatics Services Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing applications of bioinformatics for the development of algorithms and software
  • Increasing public-private sector funding for bioinformatics services
  • Rising pharmaceutical and biotech R&D expenditure
• Market Restraints
  • Concerns regarding complexity of data
• Market Opportunities
  • Reducing cost of sequencing and growing volume of data generated during sequencing
  • Increasing focus on outsourcing for the management of large volumes of data
• Market Challenges
  • Lack of well-defined standards and interoperability issues for bioinformatics analysis

Porter's Five Forces: A Strategic Tool for Navigating the Bioinformatics Services Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bioinformatics Services Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bioinformatics Services Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bioinformatics Services Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bioinformatics Services Market

A detailed market share analysis in the Bioinformatics Services Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bioinformatics Services Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bioinformatics Services Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bioinformatics Services Market

A strategic analysis of the Bioinformatics Services Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bioinformatics Services Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Applied Biological Materials, Inc., ArrayGen Technologies Pvt. Ltd., Bio-Rad Laboratories, Inc., Biomax Informatics AG, BioNome, Biosearch Technologies by LGC Group, CD Genomics, Celemics, Inc., Computomics GmbH, Creative Proteomics, Dassault Systems SE, DNAnexus, Inc., DNASTAR, Inc., Eurofins Genomics LLC, Genomax Technologies, Illumina, Inc., LC Sciences, Luminex Corporation by DiaSorin Company, PerkinElmer Inc., RayBiotech Life, Inc., SOPHiA GENETICS SA, Thermo Fisher Scientific Inc., and Waters Corporation.

Market Segmentation & Coverage

This research report categorizes the Bioinformatics Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Specialty, market is studied across Animal Biotechnology, Environmental Biotechnology, Forensic Biotechnology, Medical Biotechnology, and Plant Biotechnology.
• Based on Type, market is studied across Data Analysis, Database & Management Services, Differential Gene Expression Analysis, Drug Discovery Services, and Sequencing Services.
• Based on Application, market is studied across Chemoinformatics & Drug Design, Genomics, Metabolomics, Proteomics, and Transcriptomics.
• Based on End-User, market is studied across Academic Institutes & Research Centers, CROs, Hospitals & Clinics, and Pharmaceutical & Biotechnology Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing applications of bioinformatics for the development of algorithms and software
    • 5.1.1.2. Increasing public-private sector funding for bioinformatics services
    • 5.1.1.3. Rising pharmaceutical and biotech R&D expenditure
  • 5.1.2. Restraints
    • 5.1.2.1. Concerns regarding complexity of data
  • 5.1.3. Opportunities
    • 5.1.3.1. Reducing cost of sequencing and growing volume of data generated during sequencing
    • 5.1.3.2. Increasing focus on outsourcing for the management of large volumes of data
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of well-defined standards and interoperability issues for bioinformatics analysis
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Bioinformatics Services Market, by Specialty

• 6.1. Introduction
• 6.2. Animal Biotechnology
• 6.3. Environmental Biotechnology
• 6.4. Forensic Biotechnology
• 6.5. Medical Biotechnology
• 6.6. Plant Biotechnology

7. Bioinformatics Services Market, by Type

• 7.1. Introduction
• 7.2. Data Analysis
• 7.3. Database & Management Services
• 7.4. Differential Gene Expression Analysis
• 7.5. Drug Discovery Services
• 7.6. Sequencing Services

8. Bioinformatics Services Market, by Application

• 8.1. Introduction
• 8.2. Chemoinformatics & Drug Design
• 8.3. Genomics
• 8.4. Metabolomics
• 8.5. Proteomics
• 8.6. Transcriptomics

9. Bioinformatics Services Market, by End-User

• 9.1. Introduction
• 9.2. Academic Institutes & Research Centers
• 9.3. CROs
• 9.4. Hospitals & Clinics
• 9.5. Pharmaceutical & Biotechnology Companies

10. Americas Bioinformatics Services Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Bioinformatics Services Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Bioinformatics Services Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Agilent Technologies, Inc.
• 2. Applied Biological Materials, Inc.
• 3. ArrayGen Technologies Pvt. Ltd.
• 4. Bio-Rad Laboratories, Inc.
• 5. Biomax Informatics AG
• 6. BioNome
• 7. Biosearch Technologies by LGC Group
• 8. CD Genomics
• 9. Celemics, Inc.
• 10. Computomics GmbH
• 11. Creative Proteomics
• 12. Dassault Systems SE
• 13. DNAnexus, Inc.
• 14. DNASTAR, Inc.
• 15. Eurofins Genomics LLC
• 16. Genomax Technologies
• 17. Illumina, Inc.
• 18. LC Sciences
• 19. Luminex Corporation by DiaSorin Company
• 20. PerkinElmer Inc.
• 21. RayBiotech Life, Inc.
• 22. SOPHiA GENETICS SA
• 23. Thermo Fisher Scientific Inc.
• 24. Waters Corporation